Becton Dickinson (BDX) Other Non-Current Liabilities (2009 - 2026)
Becton Dickinson's (BDX) quarterly Other Non-Current Liabilities came in at $2.5 billion in Q1 2026, down 17.95% year-on-year from $3.0 billion in Q1 2025, and down 12.61% on a QoQ basis from $2.8 billion in Q4 2025.
Becton Dickinson (BDX) Other Non-Current Liabilities (2009 - 2026) Analysis & Trends
Becton Dickinson (BDX) has 18 years of Other Non-Current Liabilities data on file, last reported at $2.5 billion in Q1 2026.
- On a quarterly basis, Other Non-Current Liabilities fell 17.95% year-over-year to $2.5 billion in Q1 2026; TTM through Mar 2026 was $2.5 billion, a 17.95% decrease from a year earlier, with the FY2025 full-year figure at $2.6 billion, down 26.03% from the prior year.
- Other Non-Current Liabilities for Q1 2026 stood at $2.5 billion, down from $2.8 billion in the prior quarter.
- Over the last five years, Other Non-Current Liabilities for BDX reached as high as $5.1 billion in Q3 2022 and fell as low as $2.5 billion in Q1 2026.
- Historically, Other Non-Current Liabilities has averaged $3.9 billion across 5 years, with a median of $4.3 billion in 2024.
- Across the five-year window, Other Non-Current Liabilities dropped 3.01% in 2022 and slumped 30.46% in 2025, its largest moves.
- Year by year, Other Non-Current Liabilities stood at $4.9 billion in 2022, then decreased by 9.21% to $4.4 billion in 2023, then fell by 22.56% to $3.4 billion in 2024, then fell by 17.64% to $2.8 billion in 2025, then retreated by 12.61% to $2.5 billion in 2026.
- Per Business Quant data, the three most recent Other Non-Current Liabilities figures were $2.5 billion in Q1 2026, $2.8 billion in Q4 2025, and $2.6 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn |
| 10 | Baxter International | 11.17 Bn | 9.12 Bn | 891.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.46 Bn |
| Dec 31, 2025 | 2.82 Bn |
| Sep 30, 2025 | 2.63 Bn |
| Jun 30, 2025 | 2.83 Bn |
| Mar 31, 2025 | 3.00 Bn |
| Dec 31, 2024 | 3.42 Bn |
| Sep 30, 2024 | 3.56 Bn |
| Jun 30, 2024 | 4.07 Bn |
| Mar 31, 2024 | 4.30 Bn |
| Dec 31, 2023 | 4.41 Bn |
| Sep 30, 2023 | 4.58 Bn |
| Jun 30, 2023 | 4.37 Bn |
| Mar 31, 2023 | 4.47 Bn |
| Dec 31, 2022 | 4.86 Bn |
| Sep 30, 2022 | 5.05 Bn |
| Jun 30, 2022 | 4.93 Bn |
| Mar 31, 2022 | 4.97 Bn |
| Dec 31, 2021 | 5.03 Bn |
| Sep 30, 2021 | 5.21 Bn |
| Jun 30, 2021 | 5.33 Bn |